Periodontitis decreases the antiatherogenic potency of high density lipoprotein

Journal of Lipid Research

Volumn 45, Issue 1, 2004, Pages 139-147

  Pussinen, Pirkko J ^a   Jauhiainen, Matti ^b   Vilkuna Rautiainen, Tiina ^a   Sundvall, Jouko ^b   Vesanen, Marja ^a   Mattila, Kimmo ^a   Palosuo, Timo ^b   Alfthan, Georg ^b   Asikainen, Sirkka ^c  

^a UNIVERSITY OF HELSINKI   (Finland)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^c UMEÅ UNIVERSITY   (Sweden)

Author keywords

Atherosclerosis; Cholesterol efflux; HDL metabolism; Inflammation; Reverse cholesterol transport

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL ESTER; HIGH DENSITY LIPOPROTEIN; PHOSPHATIDYLCHOLINE; PHOSPHOLIPID; PHOSPHOLIPID TRANSFER PROTEIN; SPHINGOMYELIN;

ACTINOBACILLUS ACTINOMYCETEMCOMITANS; ACUTE PHASE RESPONSE; ADULT; ARTICLE; ATHEROGENESIS; CARDIOVASCULAR RISK; CHOLESTEROL TRANSPORT; FEMALE; HUMAN; HUMAN EXPERIMENT; ISCHEMIC HEART DISEASE; LIPOPROTEIN BLOOD LEVEL; LIPOPROTEIN METABOLISM; MACROPHAGE; MALE; NORMAL HUMAN; PERIODONTITIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

C-REACTIVE PROTEIN; DIET, ATHEROGENIC; FEMALE; HUMANS; KINETICS; LIPOPROTEINS, HDL; MALE; MIDDLE AGED; PARTICLE SIZE; PERIODONTITIS; PHOSPHOLIPIDS;

EID: 0842326172     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: 10.1194/jlr.M300250-JLR200     Document Type: Article

References (55)

1. Marcus, A. J., and D. P. Hajjar. 1993. Vascular transcellular signalling. J. Lipid Res. 34: 2017-2031.
2. Baranova, I., T. Vishnyakova, A. Bocharov, Z. Chen, A. T. Remaley, J. Stonik, T. L. Eggerman, and A. P. Patterson. 2002. Lipopolysaccharide down-regulates both scavenger receptor-B1 and ATP-binding cassette transporter-A1 in RAW-cells. Infect. Immun. 70: 2995-3003.
3. Levine, D., T. Parker, T. Donneley, A. Walsh, and A. Rubin. 1993. In vivo protection against endotoxin by plasma high density lipoprotein. Proc. Natl. Acad. Sci. USA. 90: 12040-12044.
4. Mackness, M. I., P. N. Durrington, and B. Mackness. 2000. How high-density lipoprotein protects against the effect of lipid peroxidation. Curr. Opin. Lipidol. 11: 383-388.
5. Fielding, C.J., and P. E. Fielding. 1995. Molecular physiology of reverse cholesterol transport. J. Lipid Res. 36: 211-228.
6. Mendez, A. J. 1997. Cholesterol efflux mediated by apolipoproteins is an active cellular process distinct from efflux mediated by passive diffusion. J. Lipid Res. 38: 1807-1821.
7. Van Dam. M. J., E. de Groot, S. M. Clee, G. K. Hovingh, R. Roelants, K. Brook, A. Wilson, A. H. Zwiderman, A. J. Smit, A. H. Smelt, A. K. Groen, M. R. Hayden, and J. J. Kastelein. 2002. Asociation between increased arterial-wall thickness and impairment in ABCA1-driven cholesterol efflux: an observational study. Lancet. 359: 37-42.
8. Sammalkorpi, K., V. Valtonen, Y. Kerttula, E. Nikkilä, and M. R. Taskinen. 1998. Changes in serum lipoprotein pattern induced by acute infections. Metabolism. 37: 859-865.
9. Laurila, A., A. Bloigu, S. Näyhä, J. Hassi, M. Leinonen, and P. Saikku. 1997. Chronic Chlamydia pneumoniae infection is associated with a serum lipid profile known to be a risk factor for atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 17: 2910-2913.
10. Pussinen, P. J., J. Metso, E. Malle, S. Barlage, T. Palosuo, W. Sattler, G. Schmitz, and M. Jauhiainen. 2001. The role of plasma phospholipid transfer protein (PLTP) in HDL remodelling in acute-phase patients. Biochim. Biophys. Acta. 1533: 153-163.
11. Feingold, K. R., I. Hardardottir, R. Memon, E. J. Krul, A. H. Moser, J. M. Taylor, and C. Grunfeld. 1993. Effect of endotoxin on cholesterol biosynthesis and distribution in serum lipoproteins in Syrian hamsters. J. Lipid Res. 34: 2147-2158.
12. Pussinen, P. J., E. Malle, J. Metso, W. Sattler, J. G. Raynes, and M. Jauhiainen. 2001. Acute-phase HDL in phospholipid transfer protein (PLTP)-mediated HDL conversion. Atherosclerosis. 155: 297-305.
13. Betts, J. C., J. K. Cheshire, S. Akira, T. Kishimoto, and P. Woo. 1993. The role of NF-kappaB and NF-IL6 transactivating factors in the synergistic activation of human serum amyloid A gene expression by interleukin-1 and interleukin-6. J. Biol. Chem. 268: 25624-25631.
14. Miida, T., T. Yamada, T. Yamadera, K. Ozaki, K. Inano, and M. Okada. 1999. Serum amyloid A protein generates pre-beta-1 highdensity lipoprotein from alpha-migrating high-density lipoprotein. Biochemistry. 38: 16958-16962.
15. Newnham, H. H., and P. J. Barter. 1990. Synergistic effects of lipid transfers and hepatic lipase in the formation of very small highdensity lipoproteins during incubation of human plasma. Biochim. Biophys. Acta. 1044: 57-64.
16. Artl, A., G. Marsche, S. Lestavel, W. Sattler, and E. Malle. 2000. Role of serum amyloid A during metabolism of acute-phase HDL by macrophages. Arterioscler. Thromb. Vasc. Biol. 20: 763-772.
17. Khovidhunkit, W., J. K. Shigenaga, A. H. Moser, K. R. Feingold, and C. Grunfeld. 2001. Cholesterol efflux by acute-phase high density lipoprotein: role of lecithin:cholesterol acyltransferase. J. Lipid Res. 42: 967-975.
18. Hardardottir, I., A. H. Moser, J. Fuller, C. Fielding, K. Feingold, and C. Grunfeld. 1996. Endotoxin and cytokines decrease serum levels and extra hepatic protein and mRNA levels of cholesteryl ester transfer protein in Syrian hamsters. J. Clin. Invest. 97: 2585-2592.
19. Ly, H., O. L. Francone, C. J. Fielding, J. K. Shigenaga, A. H. Moser, C. Grunfeld, and K. R. Feingold. 1995. Endotoxin and TNF lead to reduced plasma LCAT activity and decreased hepatic LCAT mRNA levels in Syrian hamsters. J. Lipid Res. 36: 1254-1263.
20. Laurila, A., A. Bloigu, S. Näyhä, J. Hassi, M. Leinonen, and P. Saikku. 1999. Association of Helicobacter pylori infection with elevated serum lipids. Atherosclerosis. 147: 207-210.
21. Lösche, W., F. Karapetow, A. Pohl, C. Pohl, and T. Kocher. 2000. Plasma lipid and blood glucose levels in patients with destructive periodontal disease. J. Clin. Periodontol. 27: 537-541.
22. American Academy of Periodontology. 1996. Periodontal diseases: pathogenesis and microbial factors. World Workshop in Periodontics. Consensus report. Ann. Periodontol. 1: 926-932.
23. Cutler, C. W., R. L. Machen, R. Jotwani, and A. M. Iacopino. 1999. Heightened gingival inflammation and attachment loss in type 2 diabetics with hyperlipidemia. J. Periodontol. 70: 1313-1321.
24. Katz, J., M. Y. Flugelman, A. Goldberg, and M. Heft. 2002. Association between periodontal pockets and elevated cholesterol and low density lipoprotein cholesterol levels. J. Periodontol. 73: 494-500.
25. Mattila, K., M. Vesanen, V. Valtonen, M. Nieminen, T. Palosuo, V. Rasi, and S. Asikainen. 2002. Effect of treating periodontitis on C-reactive protein levels: a pilot study. BMC Infect. Dis. 2: 30-32.
26. Pussinen, P. J., T. Vilkuna-Rautiainen, G. Alfthan, K. Mattila, and S. Asikainen. 2002. Multiserotype enzyme-linked immunosorbent assay as a diagnostic aid for periodontitis in large-scale studies. J. Clin. Microbiol. 40: 512-518.
27. Huuskonen, J., M. Ekström, E. Tahvanainen, A. Vainio, J. Metso, P. Pussinen, C. Ehnholm, V. M. Olkkonen and M. Jauhiainen. 2000. Quantification of human plasma phospholipid transfer protein (PLTP): relationship between mass and phospholipid transfer activity. Atherosclerosis. 151: 451-461.
28. 14C]-phosphatidylcholine between liposomes and human plasma high density lipoprotein. Partial purification of a transfer-stimulating plasma factor using a rapid transfer assay. Biochim. Biophys. Acta. 712: 444-452.
29. Groener, J. E. M., R. W. Pelton, and G. M. Kostner. 1986. Improved estimation of cholesteryl ester transfer/exchange activity in serum or plasma. Clin. Chem. 32: 283-286.
30. Jauhiainen, M., and P. J. Dolphin. 1986. Human plasma lecithincholesterol acyltransferase: an elucidation of catalytic mechanism. J. Biol. Chem. 261: 7032-7043.
31. Blance, P. J., E. Gong, T. M. Forte, and A. V. Nichols. 1981. Characterization of human high-density lipoproteins by gradient gel electrophoresis. Biochim. Biophys. Acta. 665: 408-419.
32. Lowry, O. H., N. J. Rosebrough, A. L. Farr, and R. J. Randall. 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193: 265-275.
33. Bligh, E. G., and W. J. Dryer. 1959. A rapid method of total lipid extraction and purification. Can. J. Med. Sci. 37: 911-917.
34. Schmitz, G., G. Assmann, and D. E. Bowyer. 1984. A quantitative densitometric method for the rapid separation and quantitation of the major tissue and lipoprotein lipids by high-performance thin-layer chromatography. I. Sample preparation, chromatography, and densitometry. J. Chromatogr. 307: 65-79.
35. Ebersole, J. L. 1990. Systemic humoral immune responses in periodontal disease. Crit. Rev. Oral Biol. Med. 1: 283-331.
36. Fredriksson, M. I., C. M. Figueredo, A. Gustafsson, K. G. Bergstrom, and B. E. Asman. 1999. Effect of periodontitis and smoking on blood leukocytes and acute-phase proteins. J. Periodontol. 70: 1355-1360.
37. Mattila, K. J., M. S. Nieminen, V. V. Valtonen, V. P. Rasi, Y. A. Kesäniemi, S. L. Syrjälä, P. S. Jungell, M. Isoluoma, K. Hietaniemi, and M. J. Jokinen. 1989. Association between dental health and acute myocardial infarction. BMJ. 298: 1579-1580.
38. DeStefano, F., R. F. Anda, H. S. Kahn, D. F. Williamson, and C. M. Russell. 1993. Dental disease and risk of coronary heart disease and mortality. BMJ. 306: 688-691.
39. Beck, J. D., J. R. Elter, G. Heiss, D. Couper, S. M. Mauriello, and S. Offenbacher. 2001. Relationship of periodontal disease to carotid artery intima-media wall thickness. Arterioscler. Thromb. Vasc. Biol. 21: 1816-1822.
40. Papapanou, P. N. 1996. Periodontal diseases: epidemiology. Ann. Periodontol. 1: 1-36.
41. Gordon, D. J., and B. M. Rifkind. 1989. High-density lipoprotein - the clinical implications of recent studies. N. Engl. J. Med. 321: 1311-1316.
42. Pussinen, P. J., P. Jousilahti, G. Alfthan, T. Palosuo, S. Asikainen, and V. Salomaa. 2003. Antibodies to periodontal pathogens are associated with coronary heart disease. Arterioscler. Thromb. Vasc. Biol. 23: 1250-1254.
43. Salonen, J. T., R. Salonen, K. Seppänen, R. Rauramaa, and J. Tuomilehto. 1991. HDL, HDL2, and HDL3 subfractions, and the risk of acute myocardial infarction. A prospective population study in eastern Finnish men. Circulation. 84: 129-139.
44. Von Eckardstein, A., J-R. Nofer, and G. Assmann. 2001. High density lipoproteins and arteriosclerosis. Arterioscler. Thromb. Vasc. Biol. 21: 13-21.
45. Epstein, S. E., Y. F. Zhou, and J. Zhu. 1999. Infection and atherosclerosis. Emerging mechanistic paradigms. Circulation. 100: e20-e28.
46. Rothblat, G. H., M. de la Llera Moya, V. Atger, G. Kellner-Weibel, D. L. Williams, and M. C. Phillips. 1999. Cell cholesterol efflux: integration of old and new observations provides new insights. J. Lipid Res. 40: 781-796.
47. Fournier, N., J. L. Paul, V. Atger, A. Cogny, T. Soni, M. de la Llera-Moya, G. Rothblat, and N. Moatti. 1997. HDL phospholipid content and composition as a major factor determining cholesterol efflux capacity from Fu5AH cells to human serum. Arterioscler. Thromb. Vasc. Biol. 17: 2685-2691.
48. Yancey, P. G., M. de la Llera-Moya, S. Swarnakar, P. Monzo, S. M. Klein, M. A. Connelly, W. J. Johnson, D. L. Williams, and G. H. Rothblat. 2000. High density lipoprotein phospholipid composition is a major determinant of the bi-directional flux and net movement of cellular free cholesterol mediated by scavenger receptor BI. J. Biol. Chem. 275: 36596-36604.
49. Horter, M. J., S. Sondermann, H. Reinecke, J. Bogdanski, A. Woltering, S. Kerber, G. Breithardt, G. Assmann, and A. von Eckardstein. 2002. Associations of HDL phospholipids and paraoxonase activity with coronary heart disease in postmenopausal women. Acta Physiol. Scand. 176: 123-130.
50. Jauhiainen, M., J. Metso, R. Pahlman, S. Blomqvist, A. van Tol, and C. Ehnholm. 1993. Human plasma phospholipid transfer protein causes high density lipoprotein conversion. J. Biol. Chem. 268: 4032-4036.
51. Syvänne, M., G. Castro, C. Dengremont, C. De Geitere, M. Jauhiainen, C. Ehnholm, S. Michelagnoli, G. Franceschini, J. Kahri, and M. R. Taskinen. 1996. Cholesterol efflux from Fu5AH hepatoma cells induced by plasma of subjects with or without coronary artery disease and non-insulin-dependent diabetes: importance of LpA-I:A-II particles and phospholipid transfer protein. Atherosclerosis. 127: 245-253.
52. Lee, M., J. Metso, M. Jauhiainen, and P. T. Kovanen. 2003. Degradation of phospholipid transfer protein (PLTP) and PLTP-generated prebeta-HDL by mast cell chymase impairs high-affinity efflux of cholesterol from macrophage foam cells. J. Biol. Chem. 278: 13539-13545.
53. Wolfbauer, G., J. J. Albers, and J. F. Oram. 1999. Phospholipid transfer protein enhances removal of cellular cholesterol and phospholipids by high-density lipoprotein apolipoproteins. Biochim. Biophys. Acta. 1439: 65-76.
54. Oka, T., T. Kujiraoka, M. Ito, T. Egashira, S. Takahashi, M. N. Nanjee, N. E. Miller J. Metso, V. M. Olkkonen C. Ehnholm, M. Jauhiainen, and H. Hattori. 2000. Distribution of phospholipid transfer protein in human plasma: presence of two forms of phospholipid transfer protein, one catalytically active and the other inactive. J. Lipid Res. 41: 1651-1657.
55. Slots, J. 1999. Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis in periodontal disease: introduction. Periodontol. 2000. 20: 7-13.